List of Tables
    Table 1. Biosimilar of Remicade Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Biosimilar of Remicade Market Trends
    Table 3. Biosimilar of Remicade Market Drivers
    Table 4. Biosimilar of Remicade Market Challenges
    Table 5. Biosimilar of Remicade Market Restraints
    Table 6. Global Biosimilar of Remicade Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Biosimilar of Remicade Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Biosimilar of Remicade Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Biosimilar of Remicade Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Biosimilar of Remicade Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Biosimilar of Remicade Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Biosimilar of Remicade Revenue Share by Player, 2017-2022
    Table 13. Global Biosimilar of Remicade Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Biosimilar of Remicade by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar of Remicade as of 2021)
    Table 15. Top Players of Biosimilar of Remicade in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Biosimilar of Remicade Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Biosimilar of Remicade Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Biosimilar of Remicade Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Biosimilar of Remicade Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Biosimilar of Remicade Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Biosimilar of Remicade Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Biosimilar of Remicade Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Biosimilar of Remicade Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Biosimilar of Remicade Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Biosimilar of Remicade Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Biosimilar of Remicade Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Biosimilar of Remicade Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Roche Company Details
    Table 31. Roche Business Overview
    Table 32. Roche Biosimilar of Remicade Product
    Table 33. Roche Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 34. Roche Recent Development
    Table 35. Amgen Company Details
    Table 36. Amgen Business Overview
    Table 37. Amgen Biosimilar of Remicade Product
    Table 38. Amgen Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 39. Amgen Recent Development
    Table 40. AbbVie Company Details
    Table 41. AbbVie Business Overview
    Table 42. AbbVie Biosimilar of Remicade Product
    Table 43. AbbVie Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 44. AbbVie Recent Development
    Table 45. Sanofi-Aventis Company Details
    Table 46. Sanofi-Aventis Business Overview
    Table 47. Sanofi-Aventis Biosimilar of Remicade Product
    Table 48. Sanofi-Aventis Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 49. Sanofi-Aventis Recent Development
    Table 50. Johnson & Johnson Company Details
    Table 51. Johnson & Johnson Business Overview
    Table 52. Johnson & Johnson Biosimilar of Remicade Product
    Table 53. Johnson & Johnson Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 54. Johnson & Johnson Recent Development
    Table 55. Pfizer Company Details
    Table 56. Pfizer Business Overview
    Table 57. Pfizer Biosimilar of Remicade Product
    Table 58. Pfizer Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 59. Pfizer Recent Development
    Table 60. Novo Nordisk Company Details
    Table 61. Novo Nordisk Business Overview
    Table 62. Novo Nordisk Biosimilar of Remicade Product
    Table 63. Novo Nordisk Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 64. Novo Nordisk Recent Development
    Table 65. Eli Lilly Company Details
    Table 66. Eli Lilly Business Overview
    Table 67. Eli Lilly Biosimilar of Remicade Product
    Table 68. Eli Lilly Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 69. Eli Lilly Recent Development
    Table 70. Novartis Company Details
    Table 71. Novartis Business Overview
    Table 72. Novartis Biosimilar of Remicade Product
    Table 73. Novartis Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 74. Novartis Recent Development
    Table 75. Merck Company Details
    Table 76. Merck Business Overview
    Table 77. Merck Biosimilar of Remicade Product
    Table 78. Merck Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 79. Merck Recent Development
    Table 80. 3sbio Company Details
    Table 81. 3sbio Business Overview
    Table 82. 3sbio Biosimilar of Remicade Product
    Table 83. 3sbio Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 84. 3sbio Recent Development
    Table 85. Changchun High Tech Company Details
    Table 86. Changchun High Tech Business Overview
    Table 87. Changchun High Tech Biosimilar of Remicade Product
    Table 88. Changchun High Tech Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 89. Changchun High Tech Recent Development
    Table 90. CP Guojian Company Details
    Table 91. CP Guojian Business Overview
    Table 92. CP Guojian Biosimilar of Remicade Product
    Table 93. CP Guojian Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 94. CP Guojian Recent Development
    Table 95. Biotech Company Details
    Table 96. Biotech Business Overview
    Table 97. Biotech Biosimilar of Remicade Product
    Table 98. Biotech Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 99. Biotech Recent Development
    Table 100. Gelgen Company Details
    Table 101. Gelgen Business Overview
    Table 102. Gelgen Biosimilar of Remicade Product
    Table 103. Gelgen Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 104. Gelgen Recent Development
    Table 105. Innovent Company Details
    Table 106. Innovent Business Overview
    Table 107. Innovent Biosimilar of Remicade Product
    Table 108. Innovent Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 109. Innovent Recent Development
    Table 110. Dong Bao Company Details
    Table 111. Dong Bao Business Overview
    Table 112. Dong Bao Biosimilar of Remicade Product
    Table 113. Dong Bao Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 114. Dong Bao Recent Development
    Table 115. Ganlee Company Details
    Table 116. Ganlee Business Overview
    Table 117. Ganlee Biosimilar of Remicade Product
    Table 118. Ganlee Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 119. Ganlee Recent Development
    Table 120. United Laboratories Company Details
    Table 121. United Laboratories Business Overview
    Table 122. United Laboratories Biosimilar of Remicade Product
    Table 123. United Laboratories Revenue in Biosimilar of Remicade Business (2017-2022) & (US$ Million)
    Table 124. United Laboratories Recent Development
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. Biosimilar of Remicade Product Picture
    Figure 2. Global Biosimilar of Remicade Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Biosimilar of Remicade Market Size 2017-2028 (US$ Million)
    Figure 4. United States Biosimilar of Remicade Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Biosimilar of Remicade Market Size 2017-2028 (US$ Million)
    Figure 6. United States Biosimilar of Remicade Market Share in Global 2017-2028
    Figure 7. Biosimilar of Remicade Report Years Considered
    Figure 8. Product Picture of Monoclonal Antibodies
    Figure 9. Product Picture of Interferon
    Figure 10. Product Picture of Erythropoietin
    Figure 11. Product Picture of Insulin
    Figure 12. Product Picture of Vaccines
    Figure 13. Product Picture of Other
    Figure 14. Global Biosimilar of Remicade Market Share by Type in 2022 & 2028
    Figure 15. Global Biosimilar of Remicade Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. Global Biosimilar of Remicade Market Share by Type (2017-2028)
    Figure 17. United States Biosimilar of Remicade Market Share by Type in 2022 & 2028
    Figure 18. United States Biosimilar of Remicade Market Size by Type (2017-2028) & (US$ Million)
    Figure 19. United States Biosimilar of Remicade Market Share by Type (2017-2028)
    Figure 20. Product Picture of Tumor
    Figure 21. Product Picture of Diabetes
    Figure 22. Product Picture of Cardiovascular
    Figure 23. Product Picture of Hemophilia
    Figure 24. Product Picture of Other
    Figure 25. Global Biosimilar of Remicade Market Share by Application in 2022 & 2028
    Figure 26. Global Biosimilar of Remicade Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. Global Biosimilar of Remicade Market Share by Application (2017-2028)
    Figure 28. United States Biosimilar of Remicade Market Share by Application in 2022 & 2028
    Figure 29. United States Biosimilar of Remicade Market Size by Application (2017-2028) & (US$ Million)
    Figure 30. United States Biosimilar of Remicade Market Share by Application (2017-2028)
    Figure 31. North America Biosimilar of Remicade Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. United States Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Canada Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Europe Biosimilar of Remicade Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. Germany Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. France Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. U.K. Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Italy Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Russia Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Asia-Pacific Biosimilar of Remicade Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 41. China Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Japan Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. South Korea Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. India Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Australia Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. China Taiwan Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Indonesia Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Thailand Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Malaysia Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Latin America Biosimilar of Remicade Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Mexico Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Brazil Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Argentina Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Middle East & Africa Biosimilar of Remicade Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 55. Turkey Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. UAE Biosimilar of Remicade Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Roche Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 59. Amgen Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 60. AbbVie Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 61. Sanofi-Aventis Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 62. Johnson & Johnson Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 63. Pfizer Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 64. Novo Nordisk Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 65. Eli Lilly Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 66. Novartis Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 67. Merck Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 68. 3sbio Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 69. Changchun High Tech Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 70. CP Guojian Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 71. Biotech Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 72. Gelgen Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 73. Innovent Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 74. Dong Bao Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 75. Ganlee Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 76. United Laboratories Revenue Growth Rate in Biosimilar of Remicade Business (2017-2022)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed